PL3504208T3 - Pochodna triazolopirazynonowa użyteczna jako inhibitor ludzkiej PDE1 - Google Patents

Pochodna triazolopirazynonowa użyteczna jako inhibitor ludzkiej PDE1

Info

Publication number
PL3504208T3
PL3504208T3 PL17761381T PL17761381T PL3504208T3 PL 3504208 T3 PL3504208 T3 PL 3504208T3 PL 17761381 T PL17761381 T PL 17761381T PL 17761381 T PL17761381 T PL 17761381T PL 3504208 T3 PL3504208 T3 PL 3504208T3
Authority
PL
Poland
Prior art keywords
derivative useful
pde1 inhibitor
triazolopyrazinone
human pde1
human
Prior art date
Application number
PL17761381T
Other languages
English (en)
Inventor
Mark David Rekhter
Qing Shi
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of PL3504208T3 publication Critical patent/PL3504208T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL17761381T 2016-08-25 2017-08-18 Pochodna triazolopirazynonowa użyteczna jako inhibitor ludzkiej PDE1 PL3504208T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662379372P 2016-08-25 2016-08-25
EP17761381.7A EP3504208B1 (en) 2016-08-25 2017-08-18 Triazolopyrazinone derivative useful as a human pde1 inhibitor
PCT/US2017/047479 WO2018039051A1 (en) 2016-08-25 2017-08-18 Triazolopyrazinone derivative useful as a human pde1 inhibitor

Publications (1)

Publication Number Publication Date
PL3504208T3 true PL3504208T3 (pl) 2020-11-16

Family

ID=59762063

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17761381T PL3504208T3 (pl) 2016-08-25 2017-08-18 Pochodna triazolopirazynonowa użyteczna jako inhibitor ludzkiej PDE1

Country Status (37)

Country Link
US (1) US10138244B2 (pl)
EP (1) EP3504208B1 (pl)
JP (1) JP6633246B2 (pl)
KR (1) KR20190028544A (pl)
CN (1) CN109641902B (pl)
AR (1) AR109328A1 (pl)
AU (1) AU2017317111A1 (pl)
BR (1) BR112019000988A2 (pl)
CA (1) CA3034828A1 (pl)
CL (1) CL2019000487A1 (pl)
CO (1) CO2019001644A2 (pl)
CR (1) CR20190078A (pl)
CY (1) CY1123406T1 (pl)
DK (1) DK3504208T3 (pl)
DO (1) DOP2019000021A (pl)
EA (1) EA201990313A1 (pl)
EC (1) ECSP19013196A (pl)
ES (1) ES2800433T3 (pl)
HR (1) HRP20201187T1 (pl)
HU (1) HUE050419T2 (pl)
JO (1) JOP20170164A1 (pl)
LT (1) LT3504208T (pl)
MA (1) MA46039B1 (pl)
MD (1) MD3504208T2 (pl)
ME (1) ME03791B (pl)
MX (1) MX2019002065A (pl)
PE (1) PE20190452A1 (pl)
PH (1) PH12019500370A1 (pl)
PL (1) PL3504208T3 (pl)
PT (1) PT3504208T (pl)
RS (1) RS60442B1 (pl)
SG (1) SG11201901311WA (pl)
SI (1) SI3504208T1 (pl)
SV (1) SV2019005838A (pl)
TN (1) TN2019000038A1 (pl)
TW (1) TWI651323B (pl)
WO (1) WO2018039051A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR112457A1 (es) 2017-08-02 2019-10-30 Lilly Co Eli Derivados de [1,2,4]triazolo[4,3-a]pirazin-6(5h)-ona
TW201920188A (zh) 2017-08-10 2019-06-01 美商美國禮來大藥廠 [1,2,4]三唑衍生物
US11453673B2 (en) 2018-02-06 2022-09-27 Eli Lilly And Company Substituted [1,2,4]triazolo[4,3-a]pyrazines as phosphodiesterase inhibitors
WO2021035157A1 (en) * 2019-08-22 2021-02-25 Intra-Cellular Therapies, Inc. Organic compounds
IL327040A (en) 2023-09-14 2026-05-01 Lilly Co Eli PDE1 inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4354027A (en) 1980-05-19 1982-10-12 Usv Pharmaceutical Corporation Triazoloquinoxalin-4-ones
WO2008072779A1 (ja) * 2006-12-13 2008-06-19 Aska Pharmaceutical Co., Ltd. キノキサリン誘導体
WO2008103357A1 (en) 2007-02-21 2008-08-28 E. I. Du Pont De Nemours And Company Fungicidal tricyclic 1,2,4-triazoles
AU2011299936A1 (en) 2010-09-07 2013-03-28 Astellas Pharma Inc. Quinoxaline compound
US9499562B2 (en) 2012-06-18 2016-11-22 Dart Neuroscience (Cayman) Ltd. Substituted thiophene- and furan-fused azolopyrimidine-5-(6H)-one compounds
US9938284B2 (en) * 2014-08-07 2018-04-10 Intra-Cellular Therapies, Inc. Organic compounds
US20160083400A1 (en) * 2014-09-18 2016-03-24 Sunovion Pharmaceuticals Inc. Tricyclic guanidine derivative
TW201629064A (zh) * 2014-10-10 2016-08-16 H 朗德貝克公司 作爲pde1抑制劑之三唑並吡酮
TWI609870B (zh) 2016-02-12 2018-01-01 美國禮來大藥廠 Pde1抑制劑

Also Published As

Publication number Publication date
MA46039B1 (fr) 2020-09-30
AU2017317111A1 (en) 2019-01-31
CO2019001644A2 (es) 2019-05-21
SI3504208T1 (sl) 2020-08-31
ES2800433T3 (es) 2020-12-30
US20180057494A1 (en) 2018-03-01
PH12019500370A1 (en) 2019-10-21
MD3504208T2 (ro) 2020-08-31
TW201819379A (zh) 2018-06-01
MX2019002065A (es) 2019-06-03
AR109328A1 (es) 2018-11-21
HRP20201187T1 (hr) 2020-11-13
CN109641902A (zh) 2019-04-16
CA3034828A1 (en) 2018-03-01
ECSP19013196A (es) 2019-03-29
PE20190452A1 (es) 2019-03-29
KR20190028544A (ko) 2019-03-18
HUE050419T2 (hu) 2020-12-28
BR112019000988A2 (pt) 2019-05-14
WO2018039051A1 (en) 2018-03-01
SG11201901311WA (en) 2019-03-28
ME03791B (me) 2021-04-20
CN109641902B (zh) 2021-06-08
CR20190078A (es) 2019-04-05
TWI651323B (zh) 2019-02-21
DK3504208T3 (da) 2020-07-27
CL2019000487A1 (es) 2019-07-12
SV2019005838A (es) 2019-04-04
PT3504208T (pt) 2020-08-31
JP2019526567A (ja) 2019-09-19
CY1123406T1 (el) 2021-12-31
EA201990313A1 (ru) 2019-07-31
EP3504208B1 (en) 2020-06-10
US10138244B2 (en) 2018-11-27
DOP2019000021A (es) 2019-02-28
JOP20170164A1 (ar) 2019-01-30
RS60442B1 (sr) 2020-07-31
EP3504208A1 (en) 2019-07-03
JP6633246B2 (ja) 2020-01-22
TN2019000038A1 (en) 2020-07-15
LT3504208T (lt) 2020-08-10

Similar Documents

Publication Publication Date Title
IL251420A0 (en) Triazolopyrazinones as pde1 inhibitors
IL255316A0 (en) Imidazo- pyrazinones as pde1 inhibitors
LT3504208T (lt) Triazolopirazinono dariniai, naudingi kaip žmogaus pde1 slopikliai
ZA201606566B (en) Halogenated quinazolin-thf-amines as pde1 inhibitors
IL246718A0 (en) Hexahydrofuropyrroles as pde1 inhibitors
GB2538767B (en) Coffin
ZA201802194B (en) Aminoazole derivative
HK40003021A (en) Triazolopyrazinone derivative useful as a human pde1 inhibitor
GB2557390B (en) A hearse
GB201621619D0 (en) Inhibitor compounds
EM28465920003S (pl) Zdobnictwo
EM28295980001S (pl) Zdobnictwo
AU2015901122A0 (en) Jewellery Box
EM27200860014S (pl) Zdobnictwo
EM27200860004S (pl) Zdobnictwo
EM27200860009S (pl) Zdobnictwo
EM27200860008S (pl) Zdobnictwo
EM27200860010S (pl) Zdobnictwo
EM27200860011S (pl) Zdobnictwo
EM27200860005S (pl) Zdobnictwo
EM27200860006S (pl) Zdobnictwo
EM27200860003S (pl) Zdobnictwo
EM27200860013S (pl) Zdobnictwo
EM27200860012S (pl) Zdobnictwo
EM27200860007S (pl) Zdobnictwo